Company Data

ProKidney Corp.

Ticker
PROK
Current Price
$0.7228 0.32%
Market Cap
$211.6M
Price Target
Refer to Report
Volume
393.0K
52wk Range
$0.4603 - $4.3499
Advanced Market Data

Overview

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient’s own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient’s own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy